Premium
Workshop 5: NAAG and NAALADase: Functional Properties in the Central and Peripheral Nervous System. Naaladase (GCPII) knockout mice are less susceptible to neuropathy and stroke
Author(s) -
Bacich D.,
O'Keefe D. S.,
Heston W. D. W.,
Callizot N.,
Poindron P.,
Baillet C.,
Tiffany C.,
Lu X. C.,
Wozniak K. M.,
Slusher B. S.
Publication year - 2002
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.81.s1.69.x
Subject(s) - glutamate carboxypeptidase ii , biology , knockout mouse , medicine , endocrinology , peripheral neuropathy , heterozygote advantage , glutamate receptor , neuroscience , biochemistry , allele , receptor , gene , diabetes mellitus , prostate , cancer
Glutamate carboxypeptidase II (GCPII, also known as N‐acetylated‐alpha‐linked acidic dipeptidase or NAALADase) knockout (KO) mice were generated by inserting a GCPII targeting cassette containing a PGK‐Neo resistance marker and stop codons in exons 1 and 2, and removal of exons 1 and 2 intron/exon boundary sequence. Embryonic stem cells were injected into C57BL6 blastocysts, and chimeric offspring born. Germline transmission was confirmed by mating the chimeras to generate heterozygous KO mice. Crossing heterozygous mice generated F2 generation mice homozygous for the null mutant, as confirmed by loss of GCPII protein. NAAG hydrolyzing activity was minimal (0.07 pmol/mg/min) in KO tissue, with normal levels (4.82 pmol/mg/min) in wild types and intermediate levels (1.73 pmol/mg/min) in heterozygotes. Preliminary neuropathy experiments showed KO mice are less affected by nerve‐crush and recover faster from the damage‐induced neuropathy, as indicated by EMG recording and nerve morphology. Similarly, GCPII KO mice subjected to high dose vitamin B6 displayed less severe neuropathy than wild types, as indicated by reduced sensory nerve conduction velocity and morphological deficits. Also, in a transient middle cerebral artery occlusion model, GCPII KO mice were significantly more resistant to the effects of cerebral ischemia than their wildtype littermates. Findings support GCPII involvement in stroke and in mediating chronic neuropathic conditions and suggest GCPII inhibitors may be useful in treatment of brain ischemia as well as peripheral neuropathies.